These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2437983)

  • 1. Tumour markers in diagnosis and management.
    Warnes TW; Smith A
    Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers for hepatocellular carcinoma.
    Wu AH; Sell S
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
    Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
    Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
    Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G
    Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
    Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
    Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.
    Melia WM; Johnson PJ; Carter S; Munro-Neville A; Williams R
    Cancer; 1981 Aug; 48(4):1004-8. PubMed ID: 6168358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
    Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
    Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
    Johnson PJ
    J Gastroenterol Hepatol; 1999 May; 14 Suppl():S32-6. PubMed ID: 10382636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
    Ferrandez-Izquierdo A; Llombart-Bosch A
    Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Takada A; Fukumori K; Yano Y; Sumie S; Okuda K; Kumashiro R; Sata M
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):641-8. PubMed ID: 12840676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellualar carcinoma serum markers.
    Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
    Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
    Sassa T; Kumada T; Nakano S; Uematsu T
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse
    Sultanik P; Ginguay A; Vandame J; Popovici T; Meritet JF; Cynober L; Pol S; Bories PN
    J Viral Hepat; 2017 Jan; 24(1):80-85. PubMed ID: 27699936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
    Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
    Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
    Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcino-fetal antigens].
    Endo Y
    Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.